THE DETRIMENTAL INFLUENCE OF FUNCTIONAL OVARIAN CYSTS DURING INVITRO FERTILIZATION CYCLES

被引:32
作者
JENKINS, JM
DAVIES, DW
ANTHONY, F
WOOD, P
GADD, SG
WATSON, RH
MASSON, GM
机构
[1] Department of Obstetrics and Gynaecology, University of Sheffield, Jessop Hospital for Women
[2] Department of Obstetrics and Gynaecology, University of Southampton, Princess Anne Hospital, Southampton SO9 4HA, Coxford Road
关键词
OVARIAN CYSTS; BUSERELIN; LHRH AGONISTS; IVF;
D O I
10.1093/oxfordjournals.humrep.a137736
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Reviewing 780 in-vitro fertilization (IVF) cycles, where buserelin was commenced in the preceding luteal phase and human menopausal gonadotrophin on day 4 of the ensuing menses, 53 cycles were identified with sonolucent cysts (30-50 mm diameter). Of the latter 53 cycles, the serum oestradiol was significantly greater on day 4 in 22 cycles abandoned for poor follicular development than in 31 cycles which proceeded to oocyte retrieval (P < 0.05). Of the 31 cycles proceeding to oocyte retrieval, nine had a day 4 serum oestradiol > 200 pmol/l (95th centile for day 4 oestradiol in patients without apparent cysts), and these cycles produced significantly fewer grade 1 embryos than the cycles with day 4 oestradiol levels less-than-or-equal-to 200 pmol/l (P < 0.05). Six of the 53 cycles with cysts resulted in conception, and all of these cycles had a day 4 serum oestradiol < 200 pmol/l. Among the 53 cycles with ovarian cysts, the serum progesterone on the day of abandonment in four cycles and on the day of human chorionic gonadotrophin administration in one nonabandoned cycle, was above the range established for 104 cycles without cysts. No significant difference was seen in day 4 serum androstenedione levels, and the day 4 serum progesterone was < 5 nmol/l in all but one patient. Functional activity of ovarian cysts is associated with an adverse influence on IVF cycles.
引用
收藏
页码:776 / 780
页数:5
相关论文
共 18 条
[1]  
Araki S., Chikazawa K., Motoyama M., Ijima K., Abe N., Tamada T., Reduction of pituitary desensitization and prolongation of gonadotrophin release by estrogen during continuous administration of gonadotrophin-releasing hormone in women: Its antagonism by progesterone, J. Clin. Endocrinol. Metab, 60, pp. 590-598, (1985)
[2]  
De Crespigny L.C., Robinson H.P., Davoren R.A.M., Fortune D., The ‘simple’ ovarian cyst: Aspirate or operate, Br. J. Obstet. Gynaecol, 96, pp. 1035-1039, (1989)
[3]  
Feldberg D., Yeshaya A., Ashkenazi J., Goldman G.A., Dicker D., Goldman J.A., Ovarian cyst formation: A complication of gonadotrophin-releasing hormone agonist therapy, Fertil. Steril, 51, (1989)
[4]  
Fleming R., Coutts J.R., Induction of multiple follicular growth in normally menstruating women with endogenous gonadotrophin suppression, Fertil. Steril, 45, pp. 226-230, (1986)
[5]  
Grazi R., Taney F.H., Gagliadi C.L., Khoury A., Von Hagen S., Weiss G., Schmidt C.L., The presence of ovarian cysts does not alter ovarian stimulation with gonadotrophins, Forty-Fourth Annual Meeting of the American Fertility Society, (1988)
[6]  
Homstein M.D., Barbieri R.L., Ravnikar V.A., McShane P.M., The effects of baseline ovarian cysts on the clinical response to controlled ovarian hyperstimulation in an in vitro fertilization program, Fertil. Steril, 52, pp. 437-440, (1989)
[7]  
Hung T.T., Tsuki A., Noninterference of ovarian cysts or endometriomas with the outcome of ovulation induction in assisted reproduction, Thirty-Sixth Annual Clinical Meeting of the American College of Obstetricians and Gynaecologists, (1988)
[8]  
Jenkins J.M., Davies D.W., Anthony F., Wood P., Gadd S.C., Watson R.H., Masson G.M., The management of functional ovarian cysts during IVF cycles, First International Meeting of the British Fertility Society, (1991)
[9]  
Karande V.C., Scott R.T., Jones G.S., Muasher S.J., Nonfunctional ovarian cysts do not affect the ipsilateral or contralateral ovarian performance during in-vitro fertilization, Hum. Reprod, 5, (1990)
[10]  
Meldrum D.R., Gutlay A.L., Wisot A., Huynh D., Hamilton F., Kempton W., Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression, Fertil. Steril, 50, (1988)